CHICAGO, IL – November 6, 2025 –– SOLIC Capital Advisors announced today that it served as financial advisor to Accelerate Diagnostics, Inc. (NASDAQ: AXDX) and its affiliate, Accelerate Diagnostics Texas, LLC, in connection with their Chapter 11 proceedings and successful sale of substantially all assets to Indaba Capital Management, L.P., a San Francisco–based investment firm and the company’s existing secured lender.
Accelerate Diagnostics, a pioneer in rapid diagnostic solutions designed to improve clinical outcomes and reduce healthcare costs, initiated its Chapter 11 process in June 2025 to facilitate a value-maximizing transaction and address legacy obligations. Following a court-supervised process in the United States Bankruptcy Court for the District of Delaware, the Company completed its sale to its stalking horse bidder Indaba.
The SOLIC team was led by Raoul Nowitz and Neil Luria.
About SOLIC Capital Advisors
SOLIC Capital Advisors is a leading investment banking and financial advisory firm specializing in complex restructurings, mergers and acquisitions, and capital markets transactions. SOLIC provides strategic and financial advice to companies, investors, and creditor groups across a wide range of industries. The firm is recognized for its deep expertise in special situations and its ability to deliver creative, value-maximizing solutions in challenging environments. For more information, visit www.soliccapital.com.